Jump to content

Draft:Steven McKnight

From Wikipedia, the free encyclopedia
  • Comment: This draft has information that is not in the article and should be added to the article. The article has information that is not in this draft. Please compare and combine the draft and the article.
    You may ask for advice about comparing and combining a draft and an article at the Teahouse. Robert McClenon (talk) 04:37, 9 November 2024 (UTC)

Steven Lanier McKnight is a professor and former chair of the Department of Biochemistry at the University of Texas Southwestern Medical School (UTSW).  His research is in the areas of transcriptional regulation, drug discovery, and protein condensates.

Early Life

[edit]

Steven (Steve) McKnight was born on August 27, 1949, and was raised in El Paso, Texas. His father Frank McKnight and his mother Sara Stevens McKnight had three children, Nancy, Elizabeth, and Steven. In high school, McKnight was an accomplished athlete but an indifferent student. He enrolled in college at UT Austin in the Fall of 1968, but he dropped out one year later. At his father’s suggestion, McKnight enlisted in the Army, and in 1970 he was sent to Viet Nam, where he served as a member of a tank crew.[1] Shortly after McKnight’s arrival in Viet Nam, a land mine destroyed their tank in an explosion that McKnight and his fellow crew members barely survived. One of McKnight’s more memorable experiences during that time was adopting a dog that became the crew’s unofficial mascot.

Education

[edit]

McKnight credits his military service with instilling a sense of purpose and discipline. Upon McKnight’s return to the United States, he re-entered college, initially with the goal of becoming a high school science teacher. During his time as an undergraduate, McKnight worked in the laboratory of developmental biologist Gary Freeman, who encouraged him to apply to graduate school. Following his graduation from the University of Texas in 1974, McKnight enrolled as a Ph.D. student at the University of Virginia, where he conducted research with Professor Oscar Miller, a pioneer in electron microscopy who had been the first scientist to visualize genes being transcribed into RNA.[2] For his doctoral research, McKnight analyzed DNA replication and RNA synthesis in embryos of the fruit fly Drosophila melanogaster.[3][4][5]

Independent Research Career

[edit]

After receiving his PhD in 1977, McKnight accepted a position as a Staff Associate at the Carnegie Institution of Washington’s Department of Embryology in Baltimore, Maryland. In the 1970s and 1980s, the Department of Embryology was at the forefront of the new science of molecular genetics, and, in particular, its application to developmental biology.[6] Don Brown, the far-sighted and charismatic leader of the Department of Embryology, had assembled a remarkable cadre of young scientists united in their determination to understand how genes are regulated and their devotion to a hands-on “small science” style of laboratory research.[7]

At the Department of Embryology, McKnight pioneered the use of molecular biological methods, including linker-scanning mutagenesis, to define the regulatory DNA sequences that comprised the promoter of the herpes simplex virus (HSV) thymidine kinase gene, the first such analysis of a eukaryotic protein-coding gene.[8] [During this time, his mentor Dr. Brown, who was famously frugal, noted that McKnight was spending an inordinate amount of money on highly purified acrylamide for gel electrophoresis, and Brown wondered whether McKnight might consider purchasing lower grade and less costly acrylamide. In response, McKnight purchased a large supply of low grade acrylamide and purified it himself. Years later, McKnight joked that this feat may have impressed Dr. Brown as much as his work on the thymidine kinase gene.]

McKnight’s work on eukaryotic promoters led him to the purification and study of gene-specific transcription factors, with particular emphasis on the manner in which they recognize their target DNA sequences. McKnight purified and isolated cDNA coding for CCAAT/Enhancer Binding Protein (C/EBP), the founding member of a broad family of transcription factors, which includes those encoded by the Myc, Fos and Jun proto-oncogenes.[9] Based on their studies of C/EBP, McKnight and his student Landschulz, with independent contributions from Peter Kim and Erin O’Shea at MIT, defined the “basic leucine zipper” (bZIP) mode of DNA binding as a dimeric parallel coiled-coil in which amino acids in an adjacent basic region recognize a bipartite DNA target.[10][11][12][13] This mode of association and DNA binding permits a large number of hetero- or homodimers starting from a much smaller number of bZIP proteins. This general strategy of combinatorial diversity has since been recognized in other families of transcription factors, such as the basic-helix-loop-helix (bHLH) family. The human genome codes for more than 40 bZIP proteins.[14]

In the late 1990s, McKnight identified the transcription factor hypoxia inducible factor 2alpha (HIF2alpha, a member of the bHLH family) and the prolyl hydroxylase enzyme that oxygenates it under normoxic conditions, thereby leading to its degradation.[15][16] This discovery, together with the growing appreciation that some cancers grow under hypoxic stress, led McKnight to screen for and identify small-molecule inhibitors of HIF2alpha and then to found Peloton Therapeutics, a biotechnology company focused on HIF2alpha inhibitors. Peloton Therapeutics was acquired by Merck in 2019,[17] and its HIF2alpha inhibitor belzutifan was approved for therapy of renal cancer by the Food and Drug Administration (FDA) in 2023.[18]

In the late 1980’s, McKnight’s group at Carnegie and the research group of Mark Ptashne at Harvard University independently conducted functional dissections of the HSV VP16 transcription factor (McKnight) and the yeast Gal4 transcription factor (Ptashne). Both groups discovered acidic regions capable of activating transcription in the apparent absence of conventional protein structure.[19][20][21] The VP16 and Gal4 activation domains represented the first examples of unstructured protein domains of low sequence complexity having defined biological function. These related discoveries initiated McKnight’s quest to understand the physical biochemistry of protein domains of low sequence complexity that are now recognized to comprise ~25% of eukaryotic proteomes and to function broadly in eukaryotic cells.[22]

Independent studies performed by McKnight at UTSW and Dirk Gorlich at the Max Planck Institute for Multidisciplinary Studies in Gottingen, Germany laid the groundwork for the mechanistic dissection of the phenomenon of biological phase separation resulting from the self-association of protein domains of low sequence complexity.[23][24][25][26] McKnight’s subsequent work on biological phase separation by protein domains of low sequence complexity revealed formation of weakly adhered structures as described decades earlier by Linus Pauling (reviewed in Kato and McKnight, 2017[27]). The weak cross-beta structures at the heart of protein phase separation are mediated by hydrogen bonding between polypeptide backbone N-H and carbonyl oxygen groups. Experimental evidence for these interactions was obtained by the use of synthetic peptides in which individual N-H groups were systematically methylated, a unique example of protein backbone “mutagenesis.” Using intein chemistry and native chemical ligation, McKnight’s team stitched synthetic peptides into the native protein sequence to systematically evaluate the importance of individual peptide N-H groups and thereby define the precise boundaries of the sequence that mediates self-association of TAR DNA-binding protein (TDP)-43.[28][29] Subtle mutations within the low complexity domain of TDP-43 enhance its self-association in a subset of patients with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), thereby leading to the formation of protein aggregates in neurons of affected individuals.

Support for Creative Science and Creative Scientists

[edit]

In 1995, after three years as Director of Research at Tularik, Inc., a San Francisco-based biotechnology company, McKnight moved to UTSW, serving as chair of the Department of Biochemistry from 1996 to 2016. Beyond UTSW, McKnight’s service to the scientific community has included serving on the Scientific Advisory Board of the Howard Hughes Medical Institute and the Institute of Molecular Pathology (Vienna, Austria), on the Board of Trustees of the Carnegie Institution of Washington, and as President of the American Society of Biochemistry and Molecular Biology.[30]

At UTSW, McKnight created a set of prizes in honor of his parents, the Sara and Frank McKnight Undergraduate Prizes in Molecular Sciences. These prizes recognize college students from across the United States who have conducted outstanding research in chemistry, biological chemistry, biophysics, or quantitative biology.[31] McKnight also established the Sara and Frank McKnight Fellowships, an endowed fund that supports research conducted by young scientists within the Department of Biochemistry at UTSW.[32]

In essays and lectures, McKnight has extolled the importance of creative and curiosity-driven scientific research and of pursuing scientific directions that are off the beaten path. In a 2009 commentary, “Unconventional Wisdom”[33] McKnight offered advice and encouragement for young scientists, as well as for older scientists who are young at heart.

References

[edit]
  1. ^ "Half a century later, Dr. Steven McKnight reflects on how war and a dog changed his life". www.utsouthwestern.edu. Retrieved 2024-11-07.
  2. ^ Hamkalo, B. A.; Miller, O. L. (1973). "Electronmicroscopy of genetic activity". Annual Review of Biochemistry. 42: 379–396. doi:10.1146/annurev.bi.42.070173.002115. ISSN 0066-4154. PMID 4581229.
  3. ^ McKnight, S. L.; Miller, O. L. (1976). "Ultrastructural patterns of RNA synthesis during early embryogenesis of Drosophila melanogaster". Cell. 8 (2): 305–319. doi:10.1016/0092-8674(76)90014-3. ISSN 0092-8674. PMID 822943.
  4. ^ McKnight, S. L.; Miller, O. L. (1977). "Electron microscopic analysis of chromatin replication in the cellular blastoderm Drosophila melanogaster embryo". Cell. 12 (3): 795–804. doi:10.1016/0092-8674(77)90278-1. ISSN 0092-8674. PMID 411576.
  5. ^ McKnight, S. L.; Miller, O. L. (1979). "Post-replicative nonribosomal transcription units in D. melanogaster embryos". Cell. 17 (3): 551–563. doi:10.1016/0092-8674(79)90263-0. ISSN 0092-8674. PMID 113103.
  6. ^ Brown, D. D. (1980–1981). "How a simple animal gene works". Harvey Lectures. 76: 27–44. ISSN 0073-0874. PMID 7129863.
  7. ^ Brown, Donald D. (2012). "Developmental biology using purified genes". Nature Medicine. 18 (10): 1496–1498. doi:10.1038/nm.2929. ISSN 1546-170X. PMID 23042361.
  8. ^ McKnight, S. L.; Kingsbury, R. (1982-07-23). "Transcriptional control signals of a eukaryotic protein-coding gene". Science (New York, N.Y.). 217 (4557): 316–324. Bibcode:1982Sci...217..316M. doi:10.1126/science.6283634. ISSN 0036-8075. PMID 6283634.
  9. ^ Landschulz, W. H.; Johnson, P. F.; Adashi, E. Y.; Graves, B. J.; McKnight, S. L. (1988). "Isolation of a recombinant copy of the gene encoding C/EBP". Genes & Development. 2 (7): 786–800. doi:10.1101/gad.2.7.786. ISSN 0890-9369. PMID 2850264.
  10. ^ Landschulz, W. H.; Johnson, P. F.; McKnight, S. L. (1988-06-24). "The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins". Science (New York, N.Y.). 240 (4860): 1759–1764. Bibcode:1988Sci...240.1759L. doi:10.1126/science.3289117. ISSN 0036-8075. PMID 3289117.
  11. ^ Landschulz, W. H.; Johnson, P. F.; McKnight, S. L. (1989-03-31). "The DNA binding domain of the rat liver nuclear protein C/EBP is bipartite". Science (New York, N.Y.). 243 (4899): 1681–1688. Bibcode:1989Sci...243.1681L. doi:10.1126/science.2494700. ISSN 0036-8075. PMID 2494700.
  12. ^ O'Shea, E. K.; Rutkowski, R.; Kim, P. S. (1989-01-27). "Evidence that the leucine zipper is a coiled coil". Science (New York, N.Y.). 243 (4890): 538–542. Bibcode:1989Sci...243..538O. doi:10.1126/science.2911757. ISSN 0036-8075. PMID 2911757.
  13. ^ Vinson, C. R.; Sigler, P. B.; McKnight, S. L. (1989-11-17). "Scissors-grip model for DNA recognition by a family of leucine zipper proteins". Science (New York, N.Y.). 246 (4932): 911–916. Bibcode:1989Sci...246..911V. doi:10.1126/science.2683088. ISSN 0036-8075. PMID 2683088.
  14. ^ Vinson, Charles; Myakishev, Max; Acharya, Asha; Mir, Alain A.; Moll, Jonathan R.; Bonovich, Maria (2002). "Classification of human B-ZIP proteins based on dimerization properties". Molecular and Cellular Biology. 22 (18): 6321–6335. doi:10.1128/MCB.22.18.6321-6335.2002. ISSN 0270-7306. PMC 135624. PMID 12192032.
  15. ^ Tian, H.; McKnight, S. L.; Russell, D. W. (1997-01-01). "Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells". Genes & Development. 11 (1): 72–82. doi:10.1101/gad.11.1.72. ISSN 0890-9369. PMID 9000051.
  16. ^ Bruick, R. K.; McKnight, S. L. (2001-11-09). "A conserved family of prolyl-4-hydroxylases that modify HIF". Science (New York, N.Y.). 294 (5545): 1337–1340. Bibcode:2001Sci...294.1337B. doi:10.1126/science.1066373. ISSN 0036-8075. PMID 11598268.
  17. ^ "Merck to Acquire Peloton Therapeutics, Bolstering Oncology Pipeline". Merck.com. Retrieved 2024-11-07.
  18. ^ Research, Center for Drug Evaluation and (2023-12-15). "FDA approves belzutifan for advanced renal cell carcinoma". FDA.
  19. ^ Triezenberg, S. J.; Kingsbury, R. C.; McKnight, S. L. (1988). "Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression". Genes & Development. 2 (6): 718–729. doi:10.1101/gad.2.6.718. ISSN 0890-9369. PMID 2843425.
  20. ^ Triezenberg, S. J.; LaMarco, K. L.; McKnight, S. L. (1988). "Evidence of DNA: protein interactions that mediate HSV-1 immediate early gene activation by VP16". Genes & Development. 2 (6): 730–742. doi:10.1101/gad.2.6.730. ISSN 0890-9369. PMID 2843426.
  21. ^ Ma, J.; Ptashne, M. (1987-10-09). "A new class of yeast transcriptional activators". Cell. 51 (1): 113–119. doi:10.1016/0092-8674(87)90015-8. ISSN 0092-8674. PMID 3115591.
  22. ^ McKnight, Steven L. (2024-04-17). "Protein domains of low sequence complexity-dark matter of the proteome". Genes & Development. 38 (5–6): 205–212. doi:10.1101/gad.351465.123. ISSN 1549-5477. PMC 11065162. PMID 38503517.
  23. ^ Frey, Steffen; Richter, Ralf P.; Görlich, Dirk (2006-11-03). "FG-rich repeats of nuclear pore proteins form a three-dimensional meshwork with hydrogel-like properties". Science (New York, N.Y.). 314 (5800): 815–817. Bibcode:2006Sci...314..815F. doi:10.1126/science.1132516. ISSN 1095-9203. PMID 17082456.
  24. ^ Frey, Steffen; Görlich, Dirk (2007-08-10). "A saturated FG-repeat hydrogel can reproduce the permeability properties of nuclear pore complexes". Cell. 130 (3): 512–523. doi:10.1016/j.cell.2007.06.024. ISSN 0092-8674. PMID 17693259.
  25. ^ Kato, Masato; Han, Tina W.; Xie, Shanhai; Shi, Kevin; Du, Xinlin; Wu, Leeju C.; Mirzaei, Hamid; Goldsmith, Elizabeth J.; Longgood, Jamie; Pei, Jimin; Grishin, Nick V.; Frantz, Douglas E.; Schneider, Jay W.; Chen, She; Li, Lin (2012-05-11). "Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels". Cell. 149 (4): 753–767. doi:10.1016/j.cell.2012.04.017. ISSN 1097-4172. PMC 6347373. PMID 22579281.
  26. ^ Han, Tina W.; Kato, Masato; Xie, Shanhai; Wu, Leeju C.; Mirzaei, Hamid; Pei, Jimin; Chen, Min; Xie, Yang; Allen, Jeffrey; Xiao, Guanghua; McKnight, Steven L. (2012-05-11). "Cell-free formation of RNA granules: bound RNAs identify features and components of cellular assemblies". Cell. 149 (4): 768–779. doi:10.1016/j.cell.2012.04.016. ISSN 1097-4172. PMID 22579282.
  27. ^ Kato, Masato; McKnight, Steven L. (2017-03-01). "Cross-β Polymerization of Low Complexity Sequence Domains". Cold Spring Harbor Perspectives in Biology. 9 (3): a023598. doi:10.1101/cshperspect.a023598. ISSN 1943-0264. PMC 5334260. PMID 27836835.
  28. ^ Zhou, Xiaoming; Sumrow, Lily; Tashiro, Kyuto; Sutherland, Lillian; Liu, Daifei; Qin, Tian; Kato, Masato; Liszczak, Glen; McKnight, Steven L. (2022). "Mutations linked to neurological disease enhance self-association of low-complexity protein sequences". Science (New York, N.Y.). 377 (6601): eabn5582. doi:10.1126/science.abn5582. ISSN 1095-9203. PMC 9610444. PMID 35771920.
  29. ^ Petsko, Gregory A.; Small, Scott A. (2022). "Elucidating the causes of neurodegeneration". Science (New York, N.Y.). 377 (6601): 31–32. Bibcode:2022Sci...377...31P. doi:10.1126/science.adc9969. ISSN 1095-9203. PMID 35771902.
  30. ^ "Past presidents". www.asbmb.org. Retrieved 2024-11-07.
  31. ^ "Sara and Frank McKnight Undergraduate Prizes in Molecular Sciences". www.utsouthwestern.edu. Retrieved 2024-11-07.
  32. ^ "Sara and Frank McKnight Fellowships". www.utsouthwestern.edu. Retrieved 2024-11-07.
  33. ^ McKnight, Steven L. (2009-09-04). "Unconventional wisdom". Cell. 138 (5): 817–819. doi:10.1016/j.cell.2009.08.016. ISSN 1097-4172. PMID 19737508.
[edit]


Retrieved from "https://wiki.riteme.site/w/index.php?title=Draft:Steven_McKnight&oldid=1256288660"